HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Fang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2022Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
7/2018Apatinib for heavily treated patients with non-small cell lung cancer: Report of a case series and literature review.
2/2018Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study.
8/2015A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.
1/2014Comparison of epidermal growth factor receptor mutations between primary tumors and lymph nodes in non-small cell lung cancer: a review and meta-analysis of published data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Fang Research Topics

Disease

8Neoplasms (Cancer)
10/2022 - 01/2012
6Asthma (Bronchial Asthma)
12/2018 - 01/2014
5Inflammation (Inflammations)
11/2022 - 01/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2014
4Fibrosis (Cirrhosis)
10/2022 - 08/2014
4Infections
04/2021 - 05/2003
4Hepatocellular Carcinoma (Hepatoma)
03/2020 - 01/2012
3B-Cell Lymphoma (Lymphoma, B Cell)
03/2022 - 09/2017
3Hypoxia (Hypoxemia)
01/2021 - 11/2012
3Lung Neoplasms (Lung Cancer)
01/2021 - 06/2017
3Melanoma (Melanoma, Malignant)
11/2018 - 10/2012
3Airway Remodeling
08/2018 - 08/2014
3Hypertension (High Blood Pressure)
01/2018 - 08/2009
3Cardiomyopathies (Cardiomyopathy)
01/2016 - 06/2009
3Pulmonary Hypertension
10/2011 - 03/2010
2Perennial Allergic Rhinitis
11/2022 - 12/2020
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 05/2015
2Cognitive Dysfunction
01/2022 - 01/2021
2Carcinogenesis
01/2022 - 09/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 07/2018
2Adenocarcinoma of Lung
01/2021 - 09/2019
2Wounds and Injuries (Trauma)
05/2019 - 12/2015
2Thrombosis (Thrombus)
02/2018 - 08/2007
2Type 2 Diabetes Mellitus (MODY)
10/2016 - 03/2010
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 06/2012
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 06/2012
2Citrullinemia
07/2014 - 11/2008
2Neuroinflammatory Diseases
02/2014 - 06/2012
2Spinal Cord Injuries (Spinal Cord Injury)
02/2014 - 04/2013
2Human Influenza (Influenza)
02/2011 - 01/2006
2Myocardial Infarction
10/2008 - 08/2007
1Chronic Cough
11/2022
1Allergic Rhinitis
11/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2022
1Hypothermia
01/2022
1Depressive Disorder (Melancholia)
01/2022
1Neuralgia (Stump Neuralgia)
10/2021
1Pain (Aches)
10/2021
1Lacrimal Duct Obstruction
09/2021
1Spontaneous Abortion (Miscarriage)
01/2021
1Septic Shock (Toxic Shock Syndrome)
01/2021
1Embolic Stroke
01/2021
1Gouty Arthritis
01/2021
1Stroke (Strokes)
01/2021
1Atrial Fibrillation
01/2021
1Arthritis (Polyarthritis)
01/2021

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2010
4Pharmaceutical PreparationsIBA
01/2022 - 10/2009
3Immunoglobulin E (IgE)IBA
11/2022 - 01/2014
3CollagenIBA
10/2022 - 12/2015
3salicylhydroxamic acid (SHAM)IBA
10/2021 - 12/2015
3EnzymesIBA
01/2021 - 11/2008
3Biomarkers (Surrogate Marker)IBA
02/2019 - 12/2015
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2018 - 03/2010
3OvalbuminIBA
12/2018 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 05/2015
3CytokinesIBA
12/2015 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
05/2015 - 10/2004
3Therapeutic UsesIBA
06/2011 - 10/2008
2AllergensIBA
11/2022 - 01/2014
2AntigensIBA
04/2021 - 11/2004
2Corticotropin-Releasing HormoneIBA
01/2021 - 01/2018
2apatinibIBA
09/2019 - 07/2018
2InterleukinsIBA
02/2019 - 10/2012
2Interleukin-6 (Interleukin 6)IBA
02/2019 - 05/2015
2Caspase 3 (Caspase-3)IBA
11/2018 - 10/2012
2Tyrosine Kinase InhibitorsIBA
07/2018 - 01/2014
2ErbB Receptors (EGF Receptor)IBA
07/2018 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 01/2012
27- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
12/2017 - 01/2016
2AntioxidantsIBA
06/2017 - 12/2015
2Androgen Receptors (Androgen Receptor)IBA
03/2015 - 03/2009
2HMGB1 Protein (HMG1)IBA
02/2014 - 06/2012
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2022
1Small Nucleolar RNA (snoRNA)IBA
10/2022
1Long Noncoding RNAIBA
10/2022
1Glycine Dehydrogenase (Decarboxylating)IBA
03/2022
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1Cell Adhesion MoleculesIBA
01/2022
1ChaperoninsIBA
01/2022
1necrostatin-1IBA
10/2021
1Circular RNAIBA
06/2021
1LipopolysaccharidesIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2021
1NucleotidesIBA
01/2021
1Uric Acid (Urate)IBA
01/2021
1cucurbitacin BIBA
01/2021
1CorticosteroneIBA
01/2021
1Contrast MediaIBA
01/2021
1CarbohydratesIBA
01/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2021
1GlucocorticoidsIBA
01/2021

Therapy/Procedure

6Therapeutics
02/2018 - 04/2003
4Denervation
11/2022 - 12/2015
2Drug Therapy (Chemotherapy)
07/2018 - 08/2015
1Anesthesia
01/2022
1Dacryocystorhinostomy
09/2021
1Ketogenic Diet
01/2021